You are here

Metformin Therapy and Diabetes Prevention in Adolescents Who Are Obese

Title: Metformin Therapy and Diabetes Prevention in Adolescents Who Are Obese.
126 views
59 downloads
Name(s): Rodríguez, Jose, author
Shearer, Barbara, author
Slawson, David C., author
Type of Resource: text
Genre: Text
Issuance: serial
Date Issued: 2007
Physical Form: computer
online resource
Extent: 1 online resource
Language(s): English
Abstract/Description: No studies have addressed the question of whether metformin reduces development of diabetes among adolescents who are obese. Metformin treatment in adolescents who are obese can modestly reduce risk factors for type 2 diabetes, including elevated body mass index (BMI), fasting insulin levels, and fasting glucose levels. (Strength of Recommendation [SOR]: C). However, metformin treatment is associated with nausea, abdominal pain, and diarrhea. (SOR: A). Because of the limited available data, metformin is not recommended for diabetes prevention in adolescents. (SOR: C).
Identifier: FSU_migr_fmr-0003 (IID)
Keywords: diabetes, obesity, metformin therapy, hypoglycemic agents
Note: Originally published in American Family Physician eISSN 1532-0650
Citation: Rodríguez, J. E., Shearer, B., & Slawson, D. C. (2007). FPIN's clinical inquiries. Metformin therapy and diabetes prevention in adolescents who are obese. American family physician, 76(9), 1357-8.
Subject(s): Diabetes
Endocrinology
Metabolism
Medical sciences
Diseases
Metabolism -- Disorders
Persistent Link to This Record: http://purl.flvc.org/fsu/fd/FSU_migr_fmr-0003
Owner Institution: FSU
Is Part of Series: Family Medicine and Rural Health Faculty Publications.
Is Part Of: American Family Physician.
Issue: 9, 76

Choose the citation style.
Rodríguez, J., Shearer, B., & Slawson, D. C. (2007). Metformin Therapy and Diabetes Prevention in Adolescents Who Are Obese. American Family Physician. Retrieved from http://purl.flvc.org/fsu/fd/FSU_migr_fmr-0003